首页> 外文期刊>The Journal of Urology >long-Term Effects of Endoscoplc Injection of Dextranomer/Hyaiuranie Acid Based Implants for Treatment of Urinary incontinence in Children with Neurogenic Bladder
【24h】

long-Term Effects of Endoscoplc Injection of Dextranomer/Hyaiuranie Acid Based Implants for Treatment of Urinary incontinence in Children with Neurogenic Bladder

机译:内镜注射右旋糖酐/透明质酸基植入物治疗神经源性膀胱炎患儿尿失禁的长期效果

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: We prospectively evaluated the efficacy of dextranomer/hyaluronic acid based implants for the endoscopic treatment of neurogenic urinary incontinence. Materials and Methods: We prospectively studied patients undergoing endoscopic injection of dextranomer/hyaluronic acid for structural incontinence beginning in October 1997. Preoperative evaluation consisted of medical history, incontinence charts, urine culture, urinary tract ultrasound and videourodynamics, which were repeated regularly during followup. At each evaluation patients were classified as cured or significantly improved (treatment success), or not significantly improved (treatment failure). Followup ranged from 1 to 13 years (mean 7.4). Results: A total of 48 patients 5 to 20 years old with congenital (45 patients) or acquired (3) neurogenic bladder suffering from severe sphincteric incompetence were included. Of the patients 30 underwent 1, 13 underwent 2 and 5 underwent 3 treatment sessions. Mean injected volume was 4.6 ml per session. Five patients had previously undergone bladder neck surgery. Two patients lost to followup in the short term were classified as treatment failures. Of the patients 45 had more than 2 years of followup, of whom 19 (39.6%) were dry, 6 (12.5%) were significantly improved and 23 (47.9%) had no significant improvement observed. Female patients achieved a significantly higher success rate than males (p = 0.05). No significant clinical or urodynamic criterion was predictive of success or failure. Posttreatment bladder deterioration developed in 10 cases (7 successes and 3 failures), which were managed by bladder augmentation.Conclusions: Endoscopic treatment of neurogenic urinary sphincter insufficiency with dextranomer/hyaluronic acid is effective in half of the patients. Recurrence of incontinence after 1 year is mainly a sign of bladder deterioration.
机译:目的:我们前瞻性评估了基于右旋糖酐/透明质酸的植入物在内镜下治疗神经性尿失禁的疗效。资料和方法:我们从1997年10月开始对接受内镜右旋糖酐/透明质酸注射治疗结构性尿失禁的患者进行前瞻性研究。术前评估包括病史,尿失禁图表,尿液培养,尿路超声检查和视频尿动力学,并在随访中定期重复。在每次评估中,将患者分类为治愈或显着改善(治疗成功)或未显着改善(治疗失败)。随访时间为1至13年(平均7.4)。结果:共纳入48例5至20岁的先天性(45例)或获得性(3)患有严重括约肌功能不全的神经源性膀胱。在30例患者中,有1例接受了治疗,13例进行了2次,5例接受了3次治疗。每节平均注射量为4.6 ml。五名患者以前接受过膀胱颈手术。短期失去随访的两名患者被分类为治疗失败。在患者中有45位进行了2年以上的随访,其中19位(39.6%)干了,6位(12.5%)得到了明显改善,23位(47.9%)没有得到明显改善。女性患者的成功率明显高于男性(p = 0.05)。没有重要的临床或尿动力学指标可预测成功或失败。治疗后的膀胱恶化发生10例(成功7例,失败3例),并通过膀胱增大进行了控制。结论:内镜下右旋糖酐/透明质酸治疗神经性尿道括约肌功能不全对一半患者有效。一年后尿失禁的复发主要是膀胱恶化的迹象。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号